Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Feasibility Randomised Controlled Trial Exploring Implementation of the Compassionate Mindful rEsilience pRogram for People With pUlmonaRY Fibrosis: The MERcURY Study (MERcURY)

19. august 2026 opdateret af: Clare McVeigh, Queen's University, Belfast

Pulmonary fibrosis (PF) is a chronic lung condition in which scar tissue gradually forms, impairing oxygen transfer and causing breathlessness. Individuals with PF frequently experience anxiety and depression, yet supportive care remains underdeveloped, and few evidence-based psychological interventions exist for this population, representing a critical gap in care.

This feasibility randomised controlled trial (RCT) evaluated the Compassionate Mindful Resilience (CMR) programme, a 4-week online, nurse-led mindfulness-based intervention designed to improve psychological outcomes in people living with PF.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Background: Pulmonary fibrosis is a progressive, irreversible fibrotic lung disease that requires long-term treatment. People with a diagnosis of pulmonary fibrosis are known to have reduced health-related quality of life, furthermore, it is common for such individuals to experience anxiety and depression. Therefore, interventions to support these individuals are essential to improve their psychological health. Mindfulness is increasing in popularity but retention in these programmes can be challenging. Condensed programmes have great potential but require statistical and individual evaluation. The Compassionate Mindful Resilience Program is a 4-week course that teaches simple, effective, evidence-based practices, skills and techniques.

Methods: This study aims to establish the feasibility of a randomised controlled trial to evaluate the effectiveness of the Compassionate Mindful Resilience Program in improving the psychosocial well-being of people with a diagnosis of pulmonary fibrosis. The trial will be conducted to test procedures, outcomes and validated tools; estimate recruitment and attrition rates; and calculate the sample size required for a future definitive multi-centre randomised controlled trial. The study will also utilise qualitative methods to explore the acceptability of the intervention to the study population. In keeping with CONSORT guidelines. The SPIRIT guidelines and checklist will be utilised to report the study.

Discussion: This study will implement a four-week mindfulness intervention and its utility for people with Pulmonary Fibrosis. The investigators aim to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by this condition. If the study demonstrates the practicability of delivering the online 4-week Compassionate Mindful Resilience program with adequate recruitment, the investigators will be able to determine the feasibility of progression to a randomised controlled clinical trial to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by Pulmonary Fibrosis.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

21

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Please Select
      • Belfast, Please Select, Det Forenede Kongerige, BT7 1NN
        • Queen's University Belfast

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • have a confirmed diagnosis of PF
  • be aged 18 years or older
  • reside in the UK or Ireland
  • have the capacity to provide informed consent
  • demonstrate a commitment to attend all four CMR sessions (demonstrated through discussion with the mindfulness teacher during screening)
  • have access to an internet-enabled device.

Exclusion Criteria:

  • No diagnosis of PF
  • under 18 years old
  • live outside of UK or Ireland
  • no capacity to provide informed consent
  • not willing to attend all four CMR sessions
  • no access to an internet-enabled device.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention group
CMR is an internationally accredited 4-week programme with 2-hour online sessions delivered via Microsoft Teams
It is an internationally accredited 4-week programme with 2-hour online sessions delivered via Microsoft Teams
Ingen indgriben: Waitlist group
This group did not receive the CMR intervention until all intervention groups had completed CMR.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Feasibility of the intervention
Tidsramme: From enrollment until the follow up interview was completed (up to 10 weeks)
Adherence
From enrollment until the follow up interview was completed (up to 10 weeks)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The feasibility of collecting data on anxiety, depression, well-being, mindfulness, resilience, and self-compassion
Tidsramme: Baseline (week 1), post-CMR (week 4), and four-week follow-up (week 8)
These were measured via online surveys at baseline, post-CMR, and four-week follow-up
Baseline (week 1), post-CMR (week 4), and four-week follow-up (week 8)

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Feasibility of recruitment and retention
Tidsramme: From recruitment until the end of the study (up to 5 months)
Measured against pre-defined recruitment and retention targets
From recruitment until the end of the study (up to 5 months)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. december 2024

Primær færdiggørelse (Faktiske)

21. april 2025

Studieafslutning (Faktiske)

18. juli 2025

Datoer for studieregistrering

Først indsendt

12. august 2026

Først indsendt, der opfyldte QC-kriterier

19. august 2026

Først opslået (Faktiske)

24. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

24. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. august 2026

Sidst verificeret

1. marts 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • MHLS 24_139
  • SB\ZA\101010662\980079 (Andet bevillings-/finansieringsnummer: The Burdett Trust)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner